September 6, 2019 | Lao Tribune

Daily Archives September 6, 2019

Singsys acclaimed with the ‘Company of the Year, 2019’ ...

Prestigious laudation to Singsys for its fore-fronting in Laravel Custom Solutions Prestigious laudation to Singsys for its fore-fronting in Laravel Custom Solutions SINGAPORE, Sept. 06, 2019 (GLOBE NEWSWIRE) — Singsys, a globally celebrated Multinational Corporation, head-quartered at Singapore with its state-of-art development center in Lucknow, India has been ranked 1st in India’s ‘Prominent Companies List’ […]Read More

AIR Worldwide Estimates Insured Losses for Hurricane Dorian In the ...

BOSTON, Sept. 06, 2019 (GLOBE NEWSWIRE) — Catastrophe risk modeling firm AIR Worldwide estimates that industry insured losses resulting from Hurricane Dorian’s impact to the Caribbean will range from USD 1.5 billion to USD 3 billion. AIR Worldwide is a Verisk (Nasdaq:VRSK) business. According to AIR, Hurricane Dorian made landfall on St. Thomas on August […]Read More

Komet Announces Corporate Update

MONTRÉAL, Sept. 06, 2019 (GLOBE NEWSWIRE) — Komet Resources Inc. (“Komet” or the “Corporation”) announces the resignation of Mr. Lucas Werner Claessens as President and Director of the Corporation as well as the resignation of Mr. Pascal Van Osta as Vice-President Exploration of the Corporation, as a result of management’s decision to sell Komet’s African […]Read More

WillScot to Participate at the D.A. Davidson Diversified Industrials ...

BALTIMORE, Sept. 06, 2019 (GLOBE NEWSWIRE) — WillScot Corporation (“WillScot”) (Nasdaq: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that Tim Boswell, Chief Financial Officer, and Matt Jacobsen, Vice President Finance, will attend D.A. Davidson’s 18th Annual Diversified Industrials & Services Conference to […]Read More

SunGen Pharma Receives Seventh ANDA Approval from US FDA

PRINCETON, N.J., Sept. 05, 2019 (GLOBE NEWSWIRE) — SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its seventh ANDA approval from the US Food and Drug Administration (FDA). The seventh approved ANDA is for Fosapreptant for Injection 150mg/vial. This drug product […]Read More